At Norgine, we have been transforming patients’ lives for over a century. We combine specialist expertise, entrepreneurial thinking and strong partnerships to bring life-changing medicines to patients across Europe. We are looking for an experienced EU Regional Training Lead (Sales Trainer) to shape and elevate the capabilities of our commercial teams across the region.
As EU Regional Training Lead, (Sales Trainer) you will develop and deliver impactful learning solutions that strengthen commercial excellence, customer engagement and leadership capability across multiple European markets. You will play a pivotal role in embedding Norgine's In-Call Effectiveness (ICE), Key Account Management (KAM) and Omnichannel frameworks, ensuring our teams have the skills and confidence to succeed.
Requirements
Key Responsibilities
We are looking for someone who brings:
Success at Norgine means embracing our values every day:
Drive
Dare
Develop
Benefits
This is an opportunity to influence capability development across Europe, support organisational transformation and help customer-facing teams deliver better outcomes for healthcare professionals and patients. If you are passionate about learning, coaching and commercial excellence, we'd love to hear from you.

Norgine is a uniquely positioned, specialty pharmaceutical and consumer healthcare company, with more than €500 million of annual revenues and a 120-year track record of bringing life-changing products to patients and consumers across their core markets of Western Europe, Australia, and New Zealand. Today’s Norgine is a nimble, innovative, and high-performing company that has been transformed by a relentless focus on operational excellence to do the right thing by patients, push boundaries, and take strides into new therapeutic areas. The company’s integrated approach – strong commercial capabilities, deep medical, regulatory and clinical expertise, in-house manufacturing, robust supply networks, and best-in-class enabling functions – ensures delivery of high-quality, transformative medicines quickly and effectively to more than 25 million patients annually.